Renal hemodynamics in renal transplant recipients. The role of reduced kidney mass and cyclosporine administration

Transplantation
C PluvioP Castellino

Abstract

It has been hypothesized that both the cyclosporine (CsA) treatment and the reduction of renal mass may affect the renal hemodynamic regulation in kidney transplant recipients. To address this question, we evaluated the renal hemodynamic response to hyperaminoacidemia (i.v. mixed amino acid infusion 3.3 mg/kg/minute for 150 minutes) in four study groups: (1) 16 renal transplant recipients (Tx), (2) 6 uninephrectomized (Nx) subjects, (3) 7 subjects treated with CsA for chronic uveitis (CsA), and (4) 9 normal controls (NC). In response to amino acid administration (AA), glomerular filtration rate (GFR) rose significantly in NC subjects (80 +/- 6 vs. 91 +/- 6 ml/minute; P<0.01) and Nx patients (57 +/- 3 vs. 68 +/- 7 ml/minute; P<0.01) and failed to increase in Tx recipients (39 +/- 3 vs. 37 +/- 3 ml/minute) and CsA-treated patients (58 +/- 3 vs. 53 +/- 4 ml/minute). Renal plasma flow (RPF) did not change in Tx recipients (243 +/- 27 vs. 235 +/- 25 ml/minute) but rose significantly in all other groups (257 +/- 17 vs. 344 +/- 33 in NX, 364 +/- 6l vs. 441 +/- 55 in CsA, 412 +/- 49 vs. 472 +/- 72 ml/min in NC subjects; P<0.05 vs. basal). Basal renal vascular resistances were significantly higher in Tx (0.29 +/- 0.04 mmHg/mlxmin; P<0.0...Continue Reading

References

Jan 1, 1992·Renal Failure·G E MobbP R Bell
Jan 1, 1991·Transplantation·J R NunleyD A Sica
Nov 1, 1990·Kidney International·T BochicchioJ Herrera-Acosta
May 8, 1986·The New England Journal of Medicine·UNKNOWN Canadian Multicentre Transplant Study Group
Jun 4, 1988·British Medical Journal·A LositoA Del Favero
Mar 1, 1988·The Journal of Urology·S L LachanceJ M Barry
Jun 1, 1987·The British Journal of Radiology·M AbsyA Al Khader
Dec 1, 1986·The British Journal of Surgery·S D ParvinP R Bell
Sep 13, 1984·The New England Journal of Medicine·B D MyersM Perlroth
Dec 1, 1983·The American Journal of Medicine·J P BoschS Glabman
May 1, 1984·The Journal of Clinical Investigation·L D DworkinB M Brenner
Feb 1, 1994·Kidney International·D M ThomasJ D Williams
Oct 1, 1955·The Journal of Clinical Investigation·M WALSERJ ORLOFF

❮ Previous
Next ❯

Citations

Jan 22, 2009·Transplantation·Esteban PorriniArmando Torres
May 2, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xavier FulladosaDaniel Serón
Mar 5, 2002·Diabetes Care·Stefano BenediniLivio Luzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.